PDL BioPharma Reports 2020 First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
PDL BioPharma (PDLI) Misses Q1 EPS by 31c
May 7, 2020 6:13 PM EDTPDL BioPharma (NASDAQ: PDLI) reported Q1 EPS of ($0.26), $0.31 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $6 million versus the consensus estimate of $37.62 million.
"We continue to execute on the strategy of... More
